Molecular regulation of microlymphatic formation and function: role of nitric oxide.
Identifieur interne : 007F41 ( Main/Exploration ); précédent : 007F40; suivant : 007F42Molecular regulation of microlymphatic formation and function: role of nitric oxide.
Auteurs : Jeroen Hagendoorn [États-Unis] ; Timothy P. Padera ; Dai Fukumura ; Rakesh K. JainSource :
- Trends in cardiovascular medicine [ 1050-1738 ] ; 2005.
Descripteurs français
- KwdFr :
- MESH :
- croissance et développement : Système lymphatique.
- métabolisme : Monoxyde d'azote, Système lymphatique.
- physiologie : Lymphangiogenèse.
- Animaux, Humains.
English descriptors
- KwdEn :
- MESH :
- chemical , metabolism : Nitric Oxide.
- growth & development : Lymphatic System.
- metabolism : Lymphatic System.
- physiology : Lymphangiogenesis.
- Animals, Humans.
Abstract
Inhibition of lymphangiogenesis prevents lymphatic cancer metastasis, whereas induction of lymphangiogenesis alleviates lymphedema in experimental animal models. The number of known molecular players that govern the formation and function of the microlymphatic system is growing. Here, we review the role of nitric oxide within the regulation of lymphatic formation and function and point out key unanswered questions for its translation into clinical therapy.
DOI: 10.1016/j.tcm.2005.06.003
PubMed: 16165013
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003C05
- to stream PubMed, to step Curation: 003C05
- to stream PubMed, to step Checkpoint: 003C05
- to stream Ncbi, to step Merge: 001F54
- to stream Ncbi, to step Curation: 001F54
- to stream Ncbi, to step Checkpoint: 001F54
- to stream Main, to step Merge: 008151
- to stream Main, to step Curation: 007F41
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Molecular regulation of microlymphatic formation and function: role of nitric oxide.</title><author><name sortKey="Hagendoorn, Jeroen" sort="Hagendoorn, Jeroen" uniqKey="Hagendoorn J" first="Jeroen" last="Hagendoorn">Jeroen Hagendoorn</name><affiliation wicri:level="2"><nlm:affiliation>E.L. Steele Laboratory for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>E.L. Steele Laboratory for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Padera, Timothy P" sort="Padera, Timothy P" uniqKey="Padera T" first="Timothy P" last="Padera">Timothy P. Padera</name></author><author><name sortKey="Fukumura, Dai" sort="Fukumura, Dai" uniqKey="Fukumura D" first="Dai" last="Fukumura">Dai Fukumura</name></author><author><name sortKey="Jain, Rakesh K" sort="Jain, Rakesh K" uniqKey="Jain R" first="Rakesh K" last="Jain">Rakesh K. Jain</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:16165013</idno><idno type="pmid">16165013</idno><idno type="doi">10.1016/j.tcm.2005.06.003</idno><idno type="wicri:Area/PubMed/Corpus">003C05</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003C05</idno><idno type="wicri:Area/PubMed/Curation">003C05</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003C05</idno><idno type="wicri:Area/PubMed/Checkpoint">003C05</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003C05</idno><idno type="wicri:Area/Ncbi/Merge">001F54</idno><idno type="wicri:Area/Ncbi/Curation">001F54</idno><idno type="wicri:Area/Ncbi/Checkpoint">001F54</idno><idno type="wicri:doubleKey">1050-1738:2005:Hagendoorn J:molecular:regulation:of</idno><idno type="wicri:Area/Main/Merge">008151</idno><idno type="wicri:Area/Main/Curation">007F41</idno><idno type="wicri:Area/Main/Exploration">007F41</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Molecular regulation of microlymphatic formation and function: role of nitric oxide.</title><author><name sortKey="Hagendoorn, Jeroen" sort="Hagendoorn, Jeroen" uniqKey="Hagendoorn J" first="Jeroen" last="Hagendoorn">Jeroen Hagendoorn</name><affiliation wicri:level="2"><nlm:affiliation>E.L. Steele Laboratory for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>E.L. Steele Laboratory for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Padera, Timothy P" sort="Padera, Timothy P" uniqKey="Padera T" first="Timothy P" last="Padera">Timothy P. Padera</name></author><author><name sortKey="Fukumura, Dai" sort="Fukumura, Dai" uniqKey="Fukumura D" first="Dai" last="Fukumura">Dai Fukumura</name></author><author><name sortKey="Jain, Rakesh K" sort="Jain, Rakesh K" uniqKey="Jain R" first="Rakesh K" last="Jain">Rakesh K. Jain</name></author></analytic><series><title level="j">Trends in cardiovascular medicine</title><idno type="ISSN">1050-1738</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Humans</term><term>Lymphangiogenesis (physiology)</term><term>Lymphatic System (growth & development)</term><term>Lymphatic System (metabolism)</term><term>Nitric Oxide (metabolism)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Humains</term><term>Lymphangiogenèse (physiologie)</term><term>Monoxyde d'azote (métabolisme)</term><term>Système lymphatique (croissance et développement)</term><term>Système lymphatique (métabolisme)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Nitric Oxide</term></keywords><keywords scheme="MESH" qualifier="croissance et développement" xml:lang="fr"><term>Système lymphatique</term></keywords><keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>Lymphatic System</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Lymphatic System</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Monoxyde d'azote</term><term>Système lymphatique</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Lymphangiogenèse</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Lymphangiogenesis</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Humains</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Inhibition of lymphangiogenesis prevents lymphatic cancer metastasis, whereas induction of lymphangiogenesis alleviates lymphedema in experimental animal models. The number of known molecular players that govern the formation and function of the microlymphatic system is growing. Here, we review the role of nitric oxide within the regulation of lymphatic formation and function and point out key unanswered questions for its translation into clinical therapy.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Massachusetts</li></region></list><tree><noCountry><name sortKey="Fukumura, Dai" sort="Fukumura, Dai" uniqKey="Fukumura D" first="Dai" last="Fukumura">Dai Fukumura</name><name sortKey="Jain, Rakesh K" sort="Jain, Rakesh K" uniqKey="Jain R" first="Rakesh K" last="Jain">Rakesh K. Jain</name><name sortKey="Padera, Timothy P" sort="Padera, Timothy P" uniqKey="Padera T" first="Timothy P" last="Padera">Timothy P. Padera</name></noCountry><country name="États-Unis"><region name="Massachusetts"><name sortKey="Hagendoorn, Jeroen" sort="Hagendoorn, Jeroen" uniqKey="Hagendoorn J" first="Jeroen" last="Hagendoorn">Jeroen Hagendoorn</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007F41 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 007F41 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:16165013
|texte= Molecular regulation of microlymphatic formation and function: role of nitric oxide.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:16165013" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |